Normally, your body is continually breaking down and rebuilding your bone. This helps keep your bones strong.

In people with multiple myeloma, the breakdown and rebuilding of your bones can become unbalanced. Over time, this can cause weak spots in the bones and can lead to serious bone problems.

Denosumab (Xgeva®) works by stopping cells that are breaking down bone from becoming overactive and may interrupt the process of bone breakdown.

SparkCures ID 134
Developed By Amgen
Brand Name Xgeva®
Generic Name Denosumab
Additional Names AMG-162, osteoprotegerin, Xgeva
Treatment Classifications

Clinical Trials


There are no resources, links or videos to display for this treatment.